Thromboembolic Complications in Splenectomized Patients with Dominantly Inherited β-Thalassemia

Acta Haematologica

Volumn 120, Issue 1, 2008, Pages 31-35

  Ohga, Shouichi ^a   Ideguchi, Hiroshi ^b   Kato, Junko ^b   Ishimura, Masataka ^a   Takada, Hidetoshi ^a   Harada, Naoki ^a   Kawanaka, Hirohumi ^a   Hattori, Yukio ^d   Kang, Dongchon ^c   Hamasaki, Naotaka ^c   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY HOSPITAL   (Japan)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; HEMOGLOBIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BETA THALASSEMIA; BLOOD; CASE REPORT; CHILD; CLINICAL FEATURE; CODON; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DOMINANT INHERITANCE; EXON; FEMALE; GENETIC ANALYSIS; GENOTYPE; HOSPITAL ADMISSION; HUMAN; INTRON; LABORATORY TEST; LUNG EMBOLISM; MALE; MUTATION; PARENT; PHENOTYPE; PHYSICAL EXAMINATION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SPLEEN; SPLENECTOMY; THROMBOCYTOSIS;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BETA-THALASSEMIA; CHILD, PRESCHOOL; DNA; FEMALE; FRAMESHIFT MUTATION; GENES, DOMINANT; HEMOGLOBINS, ABNORMAL; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; SEQUENCE DELETION; SPLENECTOMY; THROMBOEMBOLISM;

EID: 49949110433     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151601     Document Type: Article

References (23)

1. Rund D, Rachmilewitz E: Beta-thalassemia. N Engl J Med 2005;353:1135-1146.
2. Thein SL: Is it dominantly inherited beta thalassaemia or just a beta-chain variant that is highly unstable? Br J Haematol 1999;107:12-21.
3. Ohba Y: Unstable hemoglobins. Hemoglobin 1990;14:353-388.
4. Taher A, Isma'eel H, Cappellini MD: Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006;37:12-20.
5. Eldor A, Rachmilewitz EA: The hypercoagulable state in thalassemia. Blood 2002;99:36-43.
6. Ohga S, Nomura A, Takada H, Kato J, Ideguchi H, Hattori Y, Suda M, Suita S, Hara T: Dominant β-thalassemia with Hb Hradec Kralove: enhanced hemolysis in the spleen. Int J Hematol 2003;78:329-334.
7. Divoky V, Svobodova M, Indrak K, Chrobak L, Molchanova TP, Huisman TH: Hb Hradec Kralove (Hb HK) or alpha 2 beta 2 115(G17)Ala → Asp, a severely unstable hemoglobin variant resulting in a dominant beta-thalassemia trait in a Czech family. Hemoglobin 1993;17:319-328.
8. Beris P, Miescher PA, Diaz-Chico JC, Han IS, Kutlar A, Hu H, Wilson JB, Huisman TH: Inclusion body beta-thalassemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended beta chain carboxy-terminus due to a modification in codon beta 114. Blood 1988;72:801-805.
9. Kinoshita S, Iida H, Inoue S, Watanabe K, Kurihara M, Wada Y, Tsuda H, Kang D, Hamasaki N: Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005;38:908-915.
10. Chifu Y, Nakashima H, Hara T, Yokota E, Imamura T: Beta-thalassemia major resulting from a compound heterozygosity for the beta-globin gene mutation: further evidence for multiple origin and migration of the thalassemia gene. Hum Genet 1992;89:343-346.
11. Sanefuji M, Ohga S, Kira R, Yoshiura T, Hara T: Moyamoya syndrome in a splenectomized patient with β-thalassemia intermedia. J Child Neurol 2006;21:75-77.
12. Outeirino J, Casey R, White JM, Lehmann H: Haemoglobin Madrid beta 115 (G17) alanine → proline: an unstable variant associated with haemolytic anaemia. Acta Haematol 1974;52:53-60.
13. Molchanova TP, Postnikov YuV, Wilson JB, Webber BB, Gu LH, Sabio H, Waldron P, Huisman TH: Hb Madrid or alpha 2 beta (2)115(G17)Ala → Pro in a black teenager. Hemoglobin 1993;17:251-254.
14. Kim BJ, Park KW, Koh SB, Kim HK, Jung HL, Park MK, Lee DH: Stroke induced by splenectomy in hemoglobin Madrid: autopsy clues to the underlying mechanism. Blood Coagul Fibrinolysis 2005;16:141-144.
15. Kim JY, Park SS, Jung HL, Keum DH, Park H, Chang YH, Lee YJ, Cho HI: Hb Madrid [beta115(G17)Ala->1 Pro] in a Korean family with chronic hemolytic anemia. Hemoglobin 2000;24:133-138.
16. Wakamatsu C, Ichinose M, Manabe J, Fucharoen S, Sawada H, Ohga S, Nishimura J, Nukina H, Harada T, Shirahata S, Moriwaki Y, Uike N, Kozuru M, Ohi N, Mineta M, Nomiyama M, Fukumaki Y: Molecular basis of beta-thalassemia in Japan: heterogeneity and origins of mutations. Acta Haematol 1994;91:136-143.
17. Giordano PC, Harteveld CL, Michiels JJ, Terpstra W, Schelfhout LJ, Appel IM, Batelaan D, van Delft P, Plug RJ, Bernini LF: Phenotype variability of the dominant beta-thalassemia induced in four Dutch families by the rare cd121 (G → T) mutation. Ann Hematol 1998;77:249-255.
18. Honig GR, Shamsuddin M, Zaizov R, Steinherz M, Solar I, Kirschmann C: Hemoglobin Petah Tikva (alpha 110 ala replaced by asp): a new unstable variant with alpha-thalassemia-like expression. Blood 1981;57:705-711.
19. Taher A, Isma'eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD: Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 2006;96:488-491.
20. Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP: Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000;111:467-473.
21. Eldor A, Durst R, Hy-Am E, Goldfarb A, Gillis S, Rachmilewitz EA, Abramov A, Mac-Louf J, Godefray YC, De Raucourt E, Guillin MC: A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol 1999;107:739-746.
22. Flanders MM, Phansalkar AR, Crist RA, Roberts WL, Rodgers GM: Pediatric reference intervals for uncommon bleeding and thrombotic disorders. J Pediatr 2006;149:275-277.
23. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005;293:1653-1662.